PTEN has been found to enhance the chemosensitivity of multiple cancer cells, including hypopharyngeal cancer [21], endometrial carcinoma cells [22], ovarian cancer [23], and bladder cancer cells [23]. The gene discussed is PTEN; the disease is endometrial carcinoma.